Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
General Motors Financial $2.5 billion senior notes offering
The investment-grade notes are due 2030 and 2035
GrafTech International capital raise and exchange transaction
We advised an ad hoc group of noteholders and the first-lien term loan administrative and collateral agent on the transaction
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
J. M. Smucker cash tender offer
The offer involved five tranches of senior notes
Precigen $79 million preferred stock and warrants offering
We advised Precigen on the private placement
Personalis $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
American Savings Bank $405 million acquisition by an investor group
We advised American Savings Bank on the transactions
Barnes Group $750 million senior secured notes offering
The high-yield notes are part of the financing for an Apollo-led investor group’s acquisition of Barnes